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We describe tickborne encephalitis (TBE) in a monkey 
(Macaca sylvanus) after natural exposure in an area at risk 
for TBE. TBE virus was present in the brain and could be 
identiﬁ  ed as closely related to the European subtype, strain 
Neudoerﬂ  .
T
ickborne encephalitis (TBE) is a zoonotic disease 
caused by TBE virus (TBEV), a ﬂ  avivirus. There are 
3 subtypes of TBEV, the European subtype, transmitted 
by the hard tick Ixodes ricinus, and the Far Eastern and 
Siberian subtypes. Except in Austria, where mass vaccina-
tion campaigns were organized, the incidence of TBE in 
humans has increased in the past 30 years in all European 
countries with regions with risk for the disease. The aver-
age increase of TBE in 10 European countries was 311% 
from 1974–1983 to 1994–2003 (1,2). In Germany TBE in-
cidence has increased enormously during recent years.
Most TBE group viruses use rodents as maintenance 
and amplifying hosts. TBE is predominately reported in hu-
mans, seldom in dogs and horses, and is as yet unknown in 
monkeys.The clinical progress of TBE is typically biphasic. 
In humans, a nonspeciﬁ  c inﬂ  uenzalike illness develops as 
the ﬁ  rst phase of illness 7-14 days after they are bitten by a 
TBEV-positive tick. A second phase, with central nervous 
system involvement, develops in ≈30% of patients. Initial 
signs and symptoms include meningitis, encephalitis, and 
radiculitis. The case-fatality rate is 1%–2% in central Eu-
rope and 20%–40% in Siberia and the Far East.
The Study
On July 14, 2006, staggering paresis of the hind legs, 
incoordination, and intermittent opisthotonos developed in 
a female barbary macaque (Macaca sylvanus). No nystag-
mus was present. The monkey, born April 27, 2005, was 
from a group of ≈200 animals living in 3 social groups. 
The animals were kept in a large, outdoor enclosure of a 
monkey park situated in a TBE-risk area in southern Ger-
many. Four days after the onset of clinical signs, the animal 
became comatose and was euthanized. Blood was collected 
before euthanasia, and serum was prepared.
At necropsy, no macroscopic lesions were observed. 
The brain was removed and immediately frozen on dry ice 
and sectioned in 2-cm slices. Alternating slices were placed 
in 3.5% neutral buffered formalin at 4°C. After 48 h, rep-
resentative areas, including cerebral cortex, hippocampus, 
basal ganglia, and cerebellum, were embedded in parafﬁ  n. 
Sections (3–5 μm) were cut from each block and stained with 
hematoxylin and eosin for standard histopathologic evalua-
tion. For immunohistochemical detection of TBEV antigens, 
a noncommercial rabbit polyclonal hyperimmune serum (di-
lution 1:1,000) was used as described previously (3).
Histologic examination of the brain tissue could be 
satisfactorily performed despite moderate artifacts caused 
by freezing (Figure, Panel A). Moderate perivascular in-
ﬂ  ammatory cuffs and slight diffuse inﬁ  ltration of brain pa-
renchyma by mononuclear cells were observed in almost 
all brain areas, including basal ganglia and cerebellum 
(Figure, Panel B). In addition, slight mononuclear inﬂ  am-
matory inﬁ  ltrates were present in the meninges. Microglial 
nodules were not detected. Immunohistochemical testing 
demonstrated several anti-TBEV immunoreactive neurons 
and processes, mainly in Purkinje cells of the cerebellar 
cortex (Figure, Panel B), and to a lesser extent in pyrami-
dal neurons of the temporal cortex. Single neuronophagias 
were also observed.
From the frozen material, 10 samples of brain tissue 
were selected for PCR analysis, including cerebrum, cer-
ebellum, and brain stem (Table). Viral RNA was extracted 
from brain tissue with RNeasy Kit and from cerebrospinal 
ﬂ  uid  with QIAamp Viral Kit (both from QIAGEN, Hilden, 
Germany). The brain tissue was homogenized by bead-
milling (Retsch, Haan, Germany) with 3-mm stainless steel 
beads in 0.5 mL of lysis buffer, and the QIAshredder sys-
tem (QIAGEN) was used to improve homogenization. A 
modiﬁ  ed nested reverse transcription–PCR (nRT-PCR) was 
conducted with primer pairs Pp1, Pm1 (reverse transcrip-
tion and ﬁ  rst PCR), and Pp2, Pm2 (nested PCR) (4). Am-
pliﬁ  cation was done in a 50-μL reaction volume containing 
10 μL 5× buffer, 2 μL deoxynucleotide triphosphate mix 
(10 mmol/L), 2 μL enzyme mix (all from QIAGEN), 2 μL 
RNase inhibitor (Promega, Mannheim, Germany), 1.25 μL 
primers Pp1 and Pm1 (20 pmol/μL; Jena-Bioscience, Jena, 
Germany), 27.5 μL diethyl pyrocarbonate (DEPC)–treated 
water, and 4 μL RNA extract. The reaction was performed 
in an Eppendorf (Hamburg, Germany) thermal cycler for 
30 min at 60°C for RT and 15 min at 95°C for denaturation 
as the initial step, followed by 40 cycles of PCR with 30 s 
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at 94°C, 30 s at 66°C, and 1 min at 72°C. Final extension 
was 10 min at 72°C.
The second ampliﬁ  cation reaction was carried out with 
4 μL of ampliﬁ  cation product in a 50-μL reaction (25 μL 
Taq PCR Master Mix [QIAGEN], 1.25 μL of each primer 
Pp2 and Pm2 [20 pmol/μL], and 18.5 μL DEPC-treated wa-
ter). After a denaturation step of 2 min at 95°C, 30 cycles 
of 30 s at 94°C and 30 s at 65°C were performed, followed 
by 10 min at 72°C.
PCR products (178 bp) were visualized under UV 
light after electrophoresis on 1.5% agarose gel and ethid-
ium bromide staining. Bands were cut out, and DNA was 
extracted by using the QIAquick Gel Extraction Kit (QIA-
GEN). DNA sequencing was conducted by cycle sequenc-
ing, using the BigDye Terminator Cycle Sequencing Kit 
(Applied Biosystems, Darmstadt, Germany) according to 
the manufacturer’s instructions. Ampliﬁ  cation primers Pp2 
and Pm2 were also used as sequencing primers. Nucleotide 
sequences were determined on an ABI Prism 310 Genetic 
Analyzer (Applied Biosystems).
Six of the10 brain samples were positive and CSF was 
negative for TBEV by nRT-PCR (Table). The sequences of 
these 6 PCR products (178 bp) differed by only 1 nt from 
that of strain Neudoerﬂ  , the prototype strain of the Euro-
pean virus subtype.
The serum was tested for whole speciﬁ  c TBE antibod-
ies (immunoglobulin [Ig] G and IgM) by ELISA (5). Solid-
phase bound antigen and antigen conjugate were from a 
commercially available test kit (Immunozym FSME, Pro-
gen, Heidelberg, Germany). As standards, negative and 
positive test serum samples were used, and the following 
limit values were deﬁ  ned: <5 U/L, negative; 5–7 U/L, bor-
der line; 9–14 U/L, weakly positive; >14 U/L, positive; and 
>50 U/L, strongly positive. The serum of the macaque de-
scribed in this paper was positive for speciﬁ  c TBE antibod-
ies (24 U/L)
Conclusions
Experimental infections of macaques with TBEV and 
related ﬂ  aviviruses (Kyasanur Forest disease virus, Powas-
san virus) have been reported (6–8), but natural infections 
with TBE virus have not been reported previously. In our 
case, clinical signs, neuropathologic ﬁ  ndings, and immuno-
histochemical detection of TBEV antigen in neurons and of 
TBEV by nRT-PCR indicate that the macaque succumbed 
to natural TBEV infection. Although the classical multi-
Figure. A) Moderate perivascular 
inﬂ  ammatory  inﬁ   ltrates and slight 
diffuse inﬁ  ltration of brain parenchyma 
by mononuclear cells in basal ganglia 
(hematoxylin and eosin stain, bar = 
110  μm). B) Immunohistochemical 
ﬁ   ndings for tickborne encephalitis 
virus (TBEV): strong immunolabeling 
of cerebellar Purkinje cell perikaryon 
and apical dendrites (anti-TBEV, bar 
= 60 μm).
Table. Results of nested reverse transcription–PCR (nRT-PCR) analysis of the tickborne encephalitis virus (TBEV)–infected macaque
brain
Sample no.  Specimen TBEV results by nRT-PCR*  TBEV strain (sequencing) 
06F0927
 T653  Cerebellum + Neudoerfl†
 T654  Cerebellum – –
 T655  Neocortex  + Neudoerfl†
 T656  Neocortex – –
 T659  Neocortex + Neudoerfl†
 T660  Neocortex – –
 T657  Brain  stem  + Neudoerfl†
 T658  Brain  stem – –
 T661  Brain  stem + Neudoerfl
 T662  Brain  stem + Neudoerfl†
06F0926
 T663  Cerebrospinal  fluid  – –
Total 6/11
*+, virus detected; –, no virus detected.
†Differs by 1 nt from strain Neudoerfl, the prototype strain of the European virus subtype. Tickborne Encephalitis in Naturally Exposed Monkey
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nodular pattern of lesions in the brain was not observed, 
the distribution of viral antigens was comparable to that 
observed in fatal human TBEV infection with a short clini-
cal course. The TBEV was characterized as closely related 
to the European prototype strain Neudoerﬂ  , which suggests 
that the infection was acquired locally by infected ticks. 
This fact is surprising because macaques generally quickly 
remove ticks during social grooming.
The monkey park where the animal became infected 
is situated in southern Germany, close to the Bodensee 
(Bodenseekreis). This area, ﬂ  anked on the west by an area 
at high risk for TBE (Kreis Konstanz), is also at risk for 
TBE. From 1999 to 2006, a total of 29 autochthonous clini-
cal cases of TBE in humans were reported in the Bodens-
eekreis and 35 in the Kreis Konstanz (Hellenbrand W., 
pers. comm.); 19% of unvaccinated forestry workers in the 
Bodenseekreis and 15% in the Kreis Konstanz were sero-
positive for TBEV (9). The prevalence of TBEV in ticks 
was 1.2%–2.3% in the Bodenseekreis (10).
Retrospective analyses of anamnestic data from the 
affected monkey park show that TBE may have appeared 
sporadically in macaques in the past. A monkey died in 
September 1995 and another in May 2006, and TBEV anti-
gen was subsequently detected in brain tissue from the ﬁ  rst 
animal and antibodies to TBEV were detected in both ani-
mals (12 U/L and 46 U/L, respectively, by ELISA). These 
2 cases have not been systematically evaluated. Clinical 
signs of encephalitis were observed in another animal in 
1999, but it seroconverted (42 U/L, ELISA test) and re-
covered after 2 months. Thus, TBE should be considered 
as a differential diagnosis in cases of encephalitis in mon-
keys kept outdoors in areas at risk for TBE. Further sero-
epidemiologic studies are planned to determine the status 
of TBEV infection among animals in this German monkey 
park. Vaccination against TBEV should be an option to 
protect other macaques in the group.
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